✦ LIBER ✦

The specific disease burden of neuropathic pain: Results of a French nationwide survey

✍ Scribed by Nadine Attal; Michel Lanteri-Minet; Bernard Laurent; Jacques Fermanian; Didier Bouhassira

Book ID: 113839867
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 212 KB
Volume: 152
Category: Article
ISSN: 0304-3959
DOI: 10.1016/j.pain.2011.09.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HCV burden of infection in Egypt: result

HCV burden of infection in Egypt: results from a nationwide survey

✍ J. Guerra; M. Garenne; M. K. Mohamed; A. Fontanet 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Disease burden, disease manifestations a

Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: Results from a nationwide patient survey

✍ Witt, Matthias; Meier, Johanna; Hammitzsch, Ariane; Proft, Fabian; Schulze-Koops 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 714 KB

Economic burden of neuropathic pain in t

Economic burden of neuropathic pain in the United States: BEAT neuropathic pain observational study

✍ Sadosky, A.; Schaefer, C.; Mann, R.; Daniel, S.; Bergstrom, F.; Parsons, B.; Nie 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 89 KB

C 31 Epidemiology of Behçet's disease in

C 31 Epidemiology of Behçet's disease in children. A french nationwide survey

✍ Koné-Paut, I.; Bernard, JL. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 French ⚖ 81 KB

Development and preliminary validation o

Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale

✍ Galer, B. S.; Jensen, M. P. 📂 Article 📅 1997 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 775 KB

Development and preliminary validation o

Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale

✍ Galer, B. S.; Jensen, M. P. 📂 Article 📅 1997 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 775 KB

Neuropathic pain syndromes are commonly seen in clinical practice and are frequently used as pain models in testing new therapies. However, no pain scale exists with the primary purpose to measure pain in neuropathic syndromes. This paper describes the development and preliminary validation of the N